Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
9.36B | 9.38B | 9.21B | 10.58B | 10.48B | 8.47B | Gross Profit |
2.35B | 2.29B | 2.06B | 2.14B | 2.50B | 1.98B | EBIT |
1.43B | 1.30B | 1.09B | 1.25B | 1.88B | 968.00M | EBITDA |
1.88B | 1.80B | 1.81B | 1.73B | 2.42B | 1.54B | Net Income Common Stockholders |
922.00M | 905.00M | 894.00M | 793.00M | 857.00M | 478.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
418.00M | 837.00M | 548.00M | 493.00M | 459.00M | 564.00M | Total Assets |
14.97B | 15.21B | 14.63B | 14.67B | 15.52B | 16.08B | Total Debt |
5.02B | 5.02B | 4.97B | 5.15B | 5.16B | 5.62B | Net Debt |
4.60B | 4.18B | 4.42B | 4.66B | 4.70B | 5.05B | Total Liabilities |
9.03B | 9.36B | 9.10B | 9.43B | 9.73B | 9.97B | Stockholders Equity |
5.87B | 5.78B | 5.46B | 5.15B | 5.70B | 6.02B |
Cash Flow | Free Cash Flow | ||||
576.00M | 688.00M | 541.00M | 351.00M | 1.04B | 1.07B | Operating Cash Flow |
1.14B | 1.29B | 1.37B | 975.00M | 1.62B | 1.46B | Investing Cash Flow |
-486.00M | -534.00M | -432.00M | 392.00M | -29.00M | -394.00M | Financing Cash Flow |
-726.00M | -454.00M | -888.00M | -1.32B | -1.69B | -704.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
68 Neutral | $9.56B | 10.54 | 16.16% | 3.96% | 2.78% | 1.50% | |
66 Neutral | $8.86B | 12.69 | 12.52% | ― | -2.64% | 173.69% | |
63 Neutral | $25.93B | 19.35 | 18.47% | 2.35% | -7.67% | -0.58% | |
56 Neutral | $10.98B | 28.80 | 3.71% | 2.42% | -1.27% | 48.34% | |
51 Neutral | $7.24B | ― | -10.58% | 2.62% | -39.34% | -500.52% | |
49 Neutral | $1.98B | -1.10 | -21.24% | 3.61% | 1.31% | -31.23% | |
49 Neutral | $9.86B | ― | -7.56% | 3.79% | -39.35% | -120.09% |
In January 2025, Eastman Chemical‘s Steve Crawford transitioned to Executive Vice President, Methanolysis Operations and Worldwide Engineering and Construction Transformation to oversee the Kingsport Methanolysis facility’s startup. With the successful completion of this project, the company decided to eliminate his position as part of succession planning, effective June 2, 2025. Crawford’s responsibilities will be reassigned to other executives, and he will receive severance benefits for his 41 years of service.
Spark’s Take on EMN Stock
According to Spark, TipRanks’ AI Analyst, EMN is a Neutral.
Eastman Chemical’s stock receives a score of 68.25. The company demonstrates strong financial performance with efficient cost management and operational efficiency. However, technical indicators point to a bearish trend, which could pose risks in the short term. The stock is attractively valued with a low P/E ratio and a high dividend yield, making it appealing for long-term investors seeking income. Despite strong operational performance, the earnings call revealed challenges from tariffs and destocking, which may impact future growth. Overall, while Eastman Chemical shows potential, there are notable risks and uncertainties to consider.
To see Spark’s full report on EMN stock, click here.
On March 10, 2025, Eastman Chemical Company entered into a severance agreement with Brad A. Lich, outlining severance benefits in the event of certain employment terminations. The agreement includes a $2 million cash severance payment and up to four months of healthcare coverage, contingent on compliance with restrictive covenants and a release of claims.